“…This cytosolic scaffolding protein is associated with both adherens and tight junction complexes, where it serves to intracellularly tether transmembrane junction proteins to the actin cytoskeleton (Fanning and Anderson, 2009). Using the transient middle cerebral artery occlusion (tMCAO) model, researchers have recently demonstrated in vivo how ischemic stroke conditions disrupt ZO-1 expression and localization at the cell-cell border in cerebral microvessels, correlating with barrier failure and extravasation (Huang et al, 2013;Zehendner et al, 2013), an inflammatory process in which multiple cytokines are implicated. Consistent with this notion, the ability of TNF-α to disrupt ZO-1 localization to the cell-cell border in microvascular endothelial cells in vitro for example, has previously been reported (Lutgendorf et al, 2014), whilst other recent microvascular endothelial studies have demonstrated how ZO-1 dysregulation may accompany injury-specific induction of IL-6 (Chaudhuri et al, 2008;Labus et al, 2014).…”